230 related articles for article (PubMed ID: 24971644)
1. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.
Duraisingham SS; Buckland M; Dempster J; Lorenzo L; Grigoriadou S; Longhurst HJ
PLoS One; 2014; 9(6):e100324. PubMed ID: 24971644
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia.
Brent J; Guzman D; Bangs C; Grimbacher B; Fayolle C; Huissoon A; Bethune C; Thomas M; Patel S; Jolles S; Alachkar H; Kumaratne D; Baxendale H; Edgar JD; Helbert M; Hambleton S; Arkwright PD
Clin Exp Immunol; 2016 Apr; 184(1):73-82. PubMed ID: 26646609
[TBL] [Abstract][Full Text] [Related]
3. A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and
Kapousouzi A; Kalala F; Sarrou S; Farmaki E; Antonakos N; Kakkas I; Kourakli A; Labropoulou V; Kelaidi C; Tsiouma G; Dimou M; Vassilakopoulos TP; Voulgarelis M; Onoufriadis I; Papadimitriou E; Polychronopoulou S; Giamarellos-Bourboulis EJ; Symeonidis A; Hadjichristodoulou C; Germenis AE; Speletas M
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792965
[No Abstract] [Full Text] [Related]
4. Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.
Edwards ESJ; Bosco JJ; Aui PM; Stirling RG; Cameron PU; Chatelier J; Hore-Lacy F; O'Hehir RE; van Zelm MC
Front Immunol; 2019; 10():2593. PubMed ID: 31803177
[No Abstract] [Full Text] [Related]
5. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.
Compagno N; Cinetto F; Semenzato G; Agostini C
Haematologica; 2014 Jun; 99(6):1101-6. PubMed ID: 24682509
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of Specific Antibody Deficiency.
Perez EE; Ballow M
Immunol Allergy Clin North Am; 2020 Aug; 40(3):499-510. PubMed ID: 32654695
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.
Quinti I; Soresina A; Guerra A; Rondelli R; Spadaro G; Agostini C; Milito C; Trombetta AC; Visentini M; Martini H; Plebani A; Fiorilli M;
J Clin Immunol; 2011 Jun; 31(3):315-22. PubMed ID: 21365217
[TBL] [Abstract][Full Text] [Related]
8. Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.
Weinberger T; Fuleihan R; Cunningham-Rundles C; Maglione PJ
J Clin Immunol; 2019 May; 39(4):440-447. PubMed ID: 31089938
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin replacement therapy reduces chronic rhinosinusitis in patients with antibody deficiency.
Walsh JE; Gurrola JG; Graham SM; Mott SL; Ballas ZK
Int Forum Allergy Rhinol; 2017 Jan; 7(1):30-36. PubMed ID: 27552393
[TBL] [Abstract][Full Text] [Related]
10. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.
Patel SY; Carbone J; Jolles S
Front Immunol; 2019; 10():33. PubMed ID: 30800120
[TBL] [Abstract][Full Text] [Related]
11. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
12. Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults.
Slade CA; Bosco JJ; Binh Giang T; Kruse E; Stirling RG; Cameron PU; Hore-Lacy F; Sutherland MF; Barnes SL; Holdsworth S; Ojaimi S; Unglik GA; De Luca J; Patel M; McComish J; Spriggs K; Tran Y; Auyeung P; Nicholls K; O'Hehir RE; Hodgkin PD; Douglass JA; Bryant VL; van Zelm MC
Front Immunol; 2018; 9():694. PubMed ID: 29867917
[TBL] [Abstract][Full Text] [Related]
13. Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies.
Milito C; Pulvirenti F; Pesce AM; Digiulio MA; Pandolfi F; Visentini M; Quinti I
J Clin Immunol; 2014 Oct; 34(7):813-9. PubMed ID: 25047154
[TBL] [Abstract][Full Text] [Related]
14. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
[TBL] [Abstract][Full Text] [Related]
15. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.
Casulo C; Maragulia J; Zelenetz AD
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):106-11. PubMed ID: 23276889
[TBL] [Abstract][Full Text] [Related]
16. Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
Dhalla F; Lucas M; Schuh A; Bhole M; Jain R; Patel SY; Misbah S; Chapel H
J Clin Immunol; 2014 Apr; 34(3):277-82. PubMed ID: 24557494
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
Gernez Y; Baker MG; Maglione PJ
Transfusion; 2018 Dec; 58 Suppl 3(Suppl 3):3056-3064. PubMed ID: 30536429
[TBL] [Abstract][Full Text] [Related]
18. Primary hypogammaglobulinemia: The impact of early diagnosis in lung complications.
Dorna MB; Santos CJ; Castro AP; Oliveira LA; Suzuki L; Ferme AL; Carneiro-Sampaio MM; Pastorino AC
Rev Assoc Med Bras (1992); 2016 Sep; 62(6):530-536. PubMed ID: 27849230
[TBL] [Abstract][Full Text] [Related]
19. Secondary antibody deficiency.
Duraisingham SS; Buckland MS; Grigoriadou S; Longhurst HJ
Expert Rev Clin Immunol; 2014 May; 10(5):583-91. PubMed ID: 24684706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
